Key facts
- BioMech Health’s last known valuation is $84.0M (Jan 2020).
- It has raised $29.0M; the latest was Later Stage VC ($350K) in Feb 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for BioMech Health
- ·The full record, as it builds
Funding rounds
No funding rounds for BioMech Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioMech Health
Operator of a biotechnology company designed to offer real-time motion analytics for improving patient/user outcomes in healthcare. The company offers products including leading-edge sensors and mobile and web applications to provide real-time, precise, accurate and reproducible clinically relevant information and feedback, enabling clinicians to provide actionable information to monitor and improve health, quality of life for patients
- Sector
- Healthcare
- HQ
- Midlothian, VA, United States
- Founded
- 2013
- Employees
- 36
- Website
- biomechhealth.com/
- Ownership
- Privately Held (backing)
BioMech Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioMech Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioMech Health in its N-PORT filings yet. We sweep new filings monthly.